← Back to Search

Message + Financial Incentive for Booster Dose

N/A

Waitlist Available

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 weeks

Awards & highlights

Study Summary

The goal of this work is to understand whether small financial incentives and messaging can increase the take-up of COVID-19 boosters among patients empaneled at a county public health system. The motivation for this work is the relatively low take-up of COVID-19 boosters. In California, where our experiment is based, only 59% of the population has been boosted, with only 13% receiving the recommended bivalent booster (State of California, 2022).

Eligible Conditions

Booster Dose
Booster Message + Financial Incentive

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Vaccine booster

Trial Design

3Treatment groups

Experimental Treatment

Placebo Group

Group I: Message OnlyExperimental Treatment1 Intervention

Email or SMS Booster Vaccination Reminder

Group II: Message + Financial IncentiveExperimental Treatment2 Interventions

Email or SMS Booster Vaccination Reminder + Offer of a financial incentive for getting boosted in the next 2 weeks.

Group III: ControlPlacebo Group1 Intervention

No message or financial incentive

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Messaging

2022

N/A

~79480

Financial Incentive

2016

N/A

~63450

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor

905 Previous Clinical Trials

1,538,385 Total Patients Enrolled

J-PAL North AmericaUNKNOWN

1 Previous Clinical Trials

66,000 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this experiment currently underway?

"Per the details displayed on clinicaltrials.gov, this medical trial is presently searching for participants. It was initially published on December 8th 2022 and has since been updated to reflect changes as of December 31st 2022."

Answered by AI

What is the current capacity for participants in this medical research?

"Affirmative. Clinicaltrials.gov's information indicates that this trial, which was first publicized on December 8th 2022, seeks to enlist 57000 participants from 1 centre for the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

COVID-19 Booster Incentives

Mireille Jacobson 2022. "COVID-19 Booster Incentives". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05648773.